14th International Conference on Generic Drugs and Biosimilars

Date : 15th November 2018 to 16th November 2018

Place : Germany, Berlin

Website :https://generic-market.pharmaceuticalconferences.com/

Contact Person:Missy Christen

Description:

Generic Biosimilars 2018 invites all the participants from all over the world to attend “14th International Conference on Generic Drugs and Biosimilars’’ (Generic Biosimilars 2018) slated on November 15-16, 2018 Berlin, Germany which covers on all aspects of the pharmaceutical sciences, manufacturing, quality with strong emphasis on originality and scientific quality ConferenceSeries organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 1000+ Open access journals which contain over 70000 eminent personalities, reputed scientists as editorial board members, 1200 Symposium & Workshops and 5 million followers. ConferenceSeries Ltd invites all the participants across the globe to attend the "14th International Conference on Generic Drugs and Biosimilars Generic Biosimilars 2018 conveys recent developments in Generic drug marketing and production of generic drugs and contract manufacturing. A complete knowledge of a scientific discipline that described the effects of generic drug marketing and generic Pharma now explores the Scope of generic drug marketing in industry. Generic Biosimilars 2018 provides detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important trends are identified and sales forecasts by product categories and major country markets these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the generic drug market. The wider economic environment is also taken into account. For more details please visit- https://generic-market.pharmaceuticalconferences.com/ Why attend Generic Biosimilars 2018: Keynote presentation along with interactions to galvanize the scientific community. Workshop and symposiums to reach the largest assemblage of participants from the Pharma/Biotech community. A wide track of exhibitors to showcase the new and emerging technologies. Platform to global investment community to connect with stakeholders in Pharma/Biotech sector. Young Scientist/ Investigators Award geared towards best budding young research. Links to the political marketing resources in order to expand your business and research network. Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research ​2018 Highlights: 150+ Participation (70 Industry: 30 Academia) 10+ Keynote Speakers 50+ Plenary Speakers 20+ Exhibitors 14 Innovative Educational Sessions 5+ Workshops B2B Meetings Generic Biosimilars 2018 has everything you need: Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in Biosimilars & Biologics, where all attendees can interact with the panel followed by a Q&A session. Speaker and poster presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation. Editorial board meeting: Discussing on growth and development of open access Bioanalysis & Biomedicine International Journals and recruiting board members and reviewers who can support the journal. Round table meetings: Providing a platform where industry professionals meet academic experts. Over 50+ organizations and international pavilions will be exhibiting at the Generic Biosimilars 2018 conference. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies. In addition to the products and services you will have access to valuable content, including Keynote Presentations,

14th International Conference on Generic Drugs and Biosimilars will be held in Berlin,Germany on date 2018-11-16

---

Deadline for abstracts/proposals : 31st October 2018

Keynote Speakers : Keynote Speech: 1)The End of Phase 3 Clinical Trials in Biosimilars Development? Francois-Xavier Frapaise, Principal, FX Frapaise Consulting, France 2)The importance of ensuring a sustainable market for Biosimilars Erin Federman, Head of Biologics, Europe at Mylan 3)Workshop on: Biosimilars: Patient-Centricity Francois-Xavier Frapaise, Principal, FX Frapaise Consulting, France 4)Pannel discussion on: - Experience of Patient Advisory Boards - Role of patients in protocol optimizatio

Conference Highlights :Generic drugs, generic pills and generic medication Biosimilar and biologics Pharmacovigilance and safety of biosimilars Biosimilars uptake and patient safety Generics and biosimilars industry strategy Protein biotherapeutics and biosimilars Developing biosimilars and biobetters Biosimilar development challenges Pharmacology and drug developement Case study mitigating risk in biosimilar development Quality control and R&D Array of clinical trials in biosimilars Patent access and

Venue :Best Western Premier Airporthotel Fontane Berlin, Jonas-Lie-Straße, Blankenfelde-Mahlow, Germany

Check the event website for more details.